COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist

被引:0
|
作者
Oya, Kazumasa [1 ]
Ishii, Yoshiyuki [1 ]
Takeyama, Shigehiko [1 ]
Homma, Yusuke [1 ]
Nomura, Toshifumi [1 ]
机构
[1] Univ Tsukuba, Inst Med, Dept Dermatol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan
来源
JOURNAL OF DERMATOLOGY | 2024年 / 51卷 / 09期
关键词
D O I
10.1111/1346-8138.17215
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:e304 / e305
页数:2
相关论文
共 50 条
  • [1] Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus
    Sebaratnam, D. F.
    Martin, L. K.
    Rubin, A. I.
    Tran, K.
    Pas, H. H.
    Marr, P. J.
    Edmonds, J.
    Murrell, D. F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (01) : 91 - 93
  • [2] Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats
    Hammerbeck, David M.
    Burleson, Gary R.
    Schuller, Craig J.
    Vasilakos, John P.
    Tomai, Mark
    Egging, Elaine
    Cochran, Felicia R.
    Woulfe, Susan
    Miller, Richard L.
    ANTIVIRAL RESEARCH, 2007, 73 (01) : 1 - 11
  • [3] Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
    Angelopoulou, Athina
    Alexandris, Nikos
    Konstantinou, Evangelia
    Mesiakaris, Konstantinos
    Zanidis, Charilaos
    Farsalinos, Konstantinos
    Poulas, Konstantinos
    ENVIRONMENTAL RESEARCH, 2020, 188
  • [4] THE TOLL-LIKE RECEPTOR 7 AGONIST IMIQUIMOD INCREASES ETHANOL SELF-ADMINISTRATION AND INDUCES EXPRESSION OF TOLL-LIKE RECEPTOR 3
    Lovelock, D. F.
    Langston, S. E.
    Liu, W.
    Van Voorhies, K.
    Vetreno, R. P.
    Crews, F. T.
    Besheer, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 : 30 - 30
  • [5] COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response
    Jayarangaiah, Apoorva
    Kariyanna, Pramod Theetha
    Chen, Xiaoyi
    Jayarangaiah, Amog
    Kumar, Abhishek
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [6] Analysis of Toll-like receptor 7 and Toll-like receptor 9 chimeric molecules
    Willemsen, J.
    Yu, P.
    Bauer, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 35 - 35
  • [7] Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus
    Abida, O.
    Bahloul, E.
    Elloumi, N.
    Toumi, A.
    Tahri, Safa
    Ben Jmaa, M.
    Fakhfakh, R.
    Mahfoudh, N.
    Turki, H.
    Masmoudi, H.
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [8] The investigation of host genetic variants of toll-like receptor 7 and 8 in COVID-19
    Bagci, Gokhan
    Gundogdu, Oguz
    Pektas, Ayse Nur
    Bagci, Binnur
    Avci, Onur
    Gursoy, Sinan
    Kaygusuz, Kenan
    Elaldi, Nazif
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2023, 42 (08): : 586 - 602
  • [9] Cutaneous pharmacodynamics of a toll-like receptor 7 agonist, 852A, in humans
    Astry, Calvin
    Birmachu, Woubalem
    Harrison, Lester I.
    Meng, Tze-Chiang
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06): : 755 - 762
  • [10] Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures
    Meyer, T
    Nindl, I
    Schmook, T
    Ulrich, C
    Sterry, W
    Stockfleth, E
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 9 - 13